Table 8 Predictive performance of significantly increased cervicovaginal fluid pro-inflammatory mediators and foetal fibronectin
Analyte | AUC (95%CI) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | +LR | −LR | Criterion |
|---|---|---|---|---|---|---|---|---|
TNFR1a | 0.88 (0.56–0.99) | 75.0 | 100.0 | 100.0 | 88.9 | – | 0.25 | ≤11.13 |
GTP1/GTP2 ratio | ||||||||
CXCL10 | 0.68 (0.53–0.82) | 42.86 | 93.6 | 75.0 | 78.4 | 6.64 | 0.61 | >1.194 |
CXCL10 + FFN | 0.74 (0.58–0.86) | 64.29 | 79.31 | 60.0 | 82.1 | 3.11 | 0.45 | >0.36 |